Compare PRME & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | AIV |
|---|---|---|
| Founded | 2019 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 435.9M |
| IPO Year | 2022 | 1996 |
| Metric | PRME | AIV |
|---|---|---|
| Price | $2.89 | $2.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $7.56 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 87.41% |
| EPS Growth | 18.18 | ★ 616.00 |
| EPS | N/A | ★ N/A |
| Revenue | $4,632,000.00 | ★ $138,486,000.00 |
| Revenue This Year | $7.06 | N/A |
| Revenue Next Year | $47.01 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.40 | $2.89 |
| 52 Week High | $6.94 | $8.87 |
| Indicator | PRME | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 12.27 |
| Support Level | $2.68 | N/A |
| Resistance Level | $3.72 | $4.30 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 21.98 | 0.00 |
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment, and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development. Operating, and Other. The development segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. The operating segment includes residential apartments, communities with apartment homes that have achieved a stabilized level of operations. The other segment includes The Benson Hotel, the company's only hotel. The majority of revenue is gained from the Operating Segment.